Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide after SRS for Brain Metastases
NCT00717275Phase 2Terminated
- Sponsor
- University of Florida
- Start
- Sep 2008
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temozolomide in brain metastases, sponsored by University of Florida. Primary endpoint: Number of Participants Who Developed Distant Brain Failure at One Year at 1 year. Started Sep 2008; status: terminated.
02
Drugs
temozolomide
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT00717275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00717275.